Temasek’s Moving Into Power: CFO Shakeup Reshapes Strategy
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
New costs require quick yet thoughtful budget tweaks. This section highlights practical adjustments to preserve balance and grow savings.
27,302 articlesTemasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
Bitcoin trades in a tight corridor near the mid-$60k range, defying a clear bullish breakout as ETF flows wane and Fe...
An AI-backed forecast tied to Sam Altman’s ChatGPT points to SpaceX stock climbing into the mid-to-high $200s by end-...
Cardano shows a near-term buy signal, but traders warn the rebound could be brief as ADA tests key support amid a vol...
Strategy’s perpetual preferred stock has fallen from the $100 issuance price to the mid-$70s, prompting widespread in...
A personal financial disclosure reveals Trump earned more than a billion dollars from crypto ventures last year, incl...
XRP’s derivatives market shows a rare drop in open interest while large holders accumulate on-chain. The move could h...
UBS researchers say infrastructure stocks have overtaken hyperscalers in AI spending, signaling a shift in AI infrast...
A Paris court setback keeps the ownership fight over the Miraval winery alive as investors weigh the financial stake ...
J.P. Morgan updates its U.S. Analyst Focus List for July, spotlighting a dependable dividend payer. The move comes as...
XRP’s leverage washout has cooled, but the next move hinges on real buying. ETFs and spot demand must prove durable t...
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...